Abbisko Cayman Ltd Sustainability Reports
Abbisko Cayman Limited is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative small molecule oncology and immuno-oncology therapies. It focuses on precision oncology programs to fulfill unmet medical needs globally.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 655600UAX2YV03PRXN31
FIGI: BBG012R769F7
9 reports from 2021 to 2025
